[CLDX] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
23-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -2.20%
YoY- -2.71%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 1,764 3,456 1,874 1,790 1,477 620 3,647 -11.39%
PBT -9,402 -22,923 -32,307 -32,684 -31,821 -22,062 -16,807 -9.22%
Tax -8,746 -19,082 -5,090 836 -229 -137 -94 112.79%
NP -9,402 -3,841 -32,307 -32,684 -31,821 -22,062 -16,807 -9.22%
Tax Rate - - - - - - - -
Total Cost 11,166 7,297 34,181 34,474 33,298 22,682 20,454 -9.59%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -532.99 -111.14 -1,723.96 -1,825.92 -2,154.43 -3,558.39 -460.84 2.45%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -0.81 -0.42 -4.49 -4.97 -5.33 -3.71 -4.03 -23.45%
EPS Diluted -0.81 -0.41 -4.49 -4.97 -5.33 -3.71 -4.03 -23.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.